Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Simon GE, Wellman R, Shortreed SM, Johnson E, Sterling SA, Coleman KJ, Ahmedani BK, Yaseen ZS, Mosholder AD. Predicting and differentiating opioid and non-opioid drug poisonings using health records data. J Subst Use Addict Treat. 2026 Mar; 182:209861.
-
Oser CB, Sprunger JG, Hunt T, Holloway J, Chandler RK, Freisthler B, Balvanz P, Henry BF, Glasgow L, Harris DR, Walsh SL, Aldridge AP, Asman K, Blevins D, Booty MD, Fox AD, Springer SA, Kinnard EN, Knott C, LeBaron PA, Levin FR, Marks KR, McGladrey ML, Nunes EV, Oga EA, Smith MR, Smith MS, Staton M, Stevens-Watkins D, Surratt HL, Walters ST, Zarkin GA, Friedmann PD. The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial. J Subst Use Addict Treat. 2026 Feb; 181:209835.
-
Wolkowicz NR, Musket CW, Sofuoglu M, Reilly ED, MacLean RR, Portnoy GA. U.S. Military Veteran Perspectives on Barriers and Facilitators to Medication Treatment for Opioid Use Disorder. Subst Use Misuse. 2026; 61(6):858-870.
-
Rottapel RE, Stopka TJ, Friedmann PD, Hoskinson RA, Englander D, Calhoun N, Senst T, Gudas C, Koutoujian PJ, Farabee D. A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail. Addict Sci Clin Pract. 2025 Oct 27; 20(1):88.
-
Krawczyk N, Scott J, Miller M, Coulter A, Ferguson A, Frank D, Jordan A, Joudrey P, Kimmel SD, Levander XA, Potee R, Roberts KE, Russell D, Simon R, Sue KL, Suen LW, Vincent L, Voyles N, Simon C. Envisioning a Humane and Accessible US Methadone Treatment System: Generating Policy and Practice Recommendations From the Liberate Methadone Movement. Subst Use Addctn J. 2026 Apr; 47(2):316-325.
-
Ostrowski SJ, Adkins A, Goldfarb D, Kukowski M, Stratton D, Barton DJ, Pizon AF. Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study. Clin Toxicol (Phila). 2025 Nov; 63(11):897-905.
-
Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003.
-
Kyei EF, Duah A, Ansong R, Kyei GK, Zhang L. Navigating Complexities: A Comprehensive Stakeholder Analysis for Opioid Crisis Strategies in Boston. Policy Polit Nurs Pract. 2025 Nov; 26(4):238-255.
-
Hoadley A, Felix A, Hailu S, Ellis JD, Strickland JC, Rabinowitz JA, Wolinsky D, Hochheimer M, Hobelmann JG, Huhn AS. Joint Trajectories of Insomnia Severity and Quality of Life Among Adults in Opioid Use Disorder Treatment: A Longitudinal Study With Parallel Process Latent Growth Curve Modelling. J Sleep Res. 2026 Apr; 35(2):e70160.
-
Mullin DJ, Cahill A, Alford DP, Bergeron N, Cushman PA, Gonzalez G, Martin SA, Peterkin AF, Pothos EN, Pulaski M, Terrien JM, Fischer MA. Impact of Asynchronous Training on Student's Confidence and Attitudes Regarding Patients With Opioid Use Disorders. Subst Use Addctn J. 2026 Jan; 47(1):171-178.